ClinicalTrials.gov
ClinicalTrials.gov Menu

Iressa 2nd Line Phase III Study in Japan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00252707
Recruitment Status : Completed
First Posted : November 15, 2005
Last Update Posted : December 18, 2007
Sponsor:
Information provided by:
AstraZeneca